• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9355FS29
Device Problems Difficult or Delayed Positioning (1157); Migration or Expulsion of Device (1395); Positioning Problem (3009)
Patient Problems Embolism (1829); Injury (2348); No Code Available (3191)
Event Date 09/25/2018
Event Type  malfunction  
Manufacturer Narrative
This is one of two manufacturer reports being submitted for this case. please reference related manufacturer report no: 2015691-2018-04274.The edwards sapien xt transcatheter heart valve (thv) systems are indicated for use in pediatric and adult patients with a dysfunctional, non-compliant right ventricular outflow tract (rvot) conduit with a clinical indication for intervention and: pulmonary regurgitation = moderate and/or mean rvot gradient = 35 mmhg.  review of the sapien xt transcatheter heart valve with the edwards novaflex+ delivery system pulmonic procedural training manual instruct the operator on the following: when performing valve alignment and fine adjustment, ¿a gap between the thv and distal valve alignment marker may result in difficulty crossing.An overlap cannot be reversed and may prevent proper thv deployment¿.Regarding thv positioning in the landing zone:  ¿place the thv completely within the landing zone¿ and ¿use different fluoroscopic views, if uncertain about positioning¿.During manufacturing, delivery systems undergo multiple 100% inspections per standard operating procedures.These multiple inspections make it unlikely that a defect present during the manufacturing process contributed to the complaint event.Physicians are extensively trained by edwards before they are qualified to use the sapien xt thv.Training includes patient screening, device preparation, approach, deployment, imaging, procedure-specific training manuals and proctored procedures.In the pulmonic position difficulty crossing the pre-stent may be due to anatomical and/or procedural factors, including maneuvering through the pre-stent, tortuous anatomy or interaction with other cardiac structures.In this case, the delivery system was not able to pass the overlapping edges of the previously implanted non-edwards pre-stents.There was no allegation of indication of a device malfunction contributing to the procedural difficulty.The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Event Description
As reported, 29mm sapien xt case by tf approach in pulmonic position.A few month ago, two non-edwards pre-stents 45x28 were implanted in the pulmonic trunk overlapping each other.One stent more towards the pulmonic artery and the other towards the ventricle.The sapien xt valve was prepped and inserted into the patient, however, it was not possible to cross the previously implanted stents.It always got caught at the part where the stents were overlapping each other.Different maneuvers were attempted for 20 min but with no success.It was then decided to implant the valve at the position it where it got caught.During the deployment, the valve moved even more ventricular and ended up half in the stent and have in the ventricle and short time later completely embolized into the ventricle.The patient was transferred to open heart surgery for pulmonary valve replacement.
 
Manufacturer Narrative
Additional information indicates the patient is okay post savr procedure.
 
Manufacturer Narrative
Additional information indicates the patient is okay post savr procedure.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key7981743
MDR Text Key124674566
Report Number2015691-2018-04275
Device Sequence Number1
Product Code NPV
Combination Product (y/n)N
PMA/PMN Number
P130009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 09/25/2018
1 Device was Involved in the Event
2 Patient was Involved in the Event
Date FDA Received10/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/24/2020
Device Model Number9355FS29
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number0
Patient Outcome(s) Required Intervention;
Patient Age10 YR
-
-